Free Trial

First National Bank Sioux Falls Makes New Investment in Danaher Corporation $DHR

Danaher logo with Medical background

Key Points

  • First National Bank Sioux Falls acquired 4,521 shares of Danaher Corporation (NYSE:DHR) valued at approximately $893,000 in the second quarter.
  • Wall Street analysts have a predominantly positive outlook on Danaher, with an average target price of $246.35 and 17 out of 20 analysts rating it as a "Buy."
  • Danaher announced a quarterly dividend of $0.32 per share, with the ex-dividend date set for September 26, reflecting a dividend yield of 0.7%.
  • Interested in Danaher? Here are five stocks we like better.

First National Bank Sioux Falls acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,521 shares of the conglomerate's stock, valued at approximately $893,000.

Other hedge funds also recently modified their holdings of the company. GHP Investment Advisors Inc. lifted its position in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares during the period. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter worth approximately $27,000. Sierra Ocean LLC lifted its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in shares of Danaher during the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC lifted its position in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares during the period. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on DHR shares. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Robert W. Baird raised their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Wells Fargo & Company cut their target price on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 23rd. Finally, Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a report on Friday, July 11th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $246.35.

View Our Latest Research Report on Danaher

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.10% of the company's stock.

Danaher Trading Down 2.6%

DHR stock opened at $190.07 on Friday. The business has a fifty day moving average price of $201.21 and a 200 day moving average price of $198.90. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The stock has a market capitalization of $136.10 billion, a price-to-earnings ratio of 40.44, a P/E/G ratio of 2.72 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's revenue was up 3.4% on a year-over-year basis. During the same period last year, the firm posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's dividend payout ratio (DPR) is 27.23%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.